The adipocyte as an endocrine cell

Current Opinion in Endocrinology and Diabetes

Volumn 10, Issue 5, 2003, Pages 317-321

  Mattison, Rebecca ^a   Jensen, Michael ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

Adiponectin; Leptin; Resistin

Indexed keywords

ADIPONECTIN; ANGIOTENSINOGEN; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; CELL FUNCTION; CENTRAL NERVOUS SYSTEM; ENDOCRINE CELL; NONHUMAN; REVIEW;

EID: 33646861896     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200310000-00002     Document Type: Review

References (26)

1. Ahima RS, Flier JS: Adipose tissue as an endocrine organ. Trends Endocrinol Metab 2000, 11:327-332.
2. Jensen MD, Hensrud DD, O'Brien PC, et al.: Collection and interpretation of plasma leptin concentration data in humans. Obes Res 1999, 7:241-245.
3. Sinha M, Ohannesian JP, Heiman ML, et al.: Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 1996, 97:1344-1347.
4. Kolaczynski JW, Ohannesian JP, Considine R, et al.: Response of leptin to short-term and prolonged overfeeding in humans. J Clin Endocrinol Metab 1996, 81:4162-4165.
5. Boden G, Chen X, Mozzoli M, et al.: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996, 81:3419-3423.
6. Salomon F, Cuneo RC, Hesp R, et al.: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989, 321:1797-1803.
7. Rosenbaum M, Murphy EM, Heymsfield SB, et al.: Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones. J Clin Endocrinol Metab 2002, 87:2391-2394.
8. Chan JL, Heist K, DePaoli AM, et al.: The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest 2003, 111:1409-1421.
9. Heymsfield SB, Greenberg AS, Fujioka K, et al.: Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 1999, 282:1568-1575.
10. Oral EA, Simha V, Ruiz E, et al.: Leptin-replacement therapy for lipodystrophy. N Engl J Med 2002, 346:570-578.
11. Diez JJ, Iglesias P: The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 2003, 148:293-300.
12. Yamauchi T, Kamon J, Ho Y, et al.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762-769. This paper describes the discovery of the adiponectin receptor. Without a receptor it is difficult to attribute hormonal effects to a compound.
13. Tikhonoff V, Staessen JA: Hormonal regulation of human adipocytes at the cross-roads between obesity and hypertension. J Hypertens 2002, 20:839-841.
14. Steppan CM, Bailey ST, Bhat S, et al.: The hormone resistin links obesity to diabetes. Nature 2001, 409:307-312.
15. Rajala MW, Obici S, Scherer PE, et al.: Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J Clin Invest 2003, 111:225-230.
16. McTernan PG, McTernan CL, Chetty R, et al.: Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 2002, 87:2407-2410.
17. Hotamisligil GS: The irresistible biology of resistin. J Clin Invest 2003, 111:173-174. An excellent overview of resistin by a world authority on adipocyte-derived peptides.
18. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
19. Coppack SW: Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001, 60:349-356.
20. Ofei F, Hurel S, Newkirk J, et al.: Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM. Diabetes 1996, 45:881-885.
21. Bastard JP, Maachi M, Van Nhieu JT, et al.: Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
22. van Hall G, Steensberg A, Sacchetti M, et al.: Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 2003, 88:3005-3010.
23. Jensen MD: Cytokine regulation of lipolysis in humans? [editorial]. J Clin Endocrinol Metab 2003, 88:3003-3004.
24. Juge-Aubry CE, Somm E, Giusti V, et al.: Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003, 52:1104-1110.
25. Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 2002, 13:51-59.
26. Loskutoff DJ, Samad F: The adipocyte and hemostatic balance in obesity: studies of PAI-1. Arterioscler Thromb Vasc Biol 1998, 18:1-6.